Mu Feng
Executive Director and Executive Vice President of BGI Group and CEO of MGI.
Mu Feng participated in or hosted the completion of the
International Human Genome Project 1% project, the Rice Genome Project, the
National “Ninth Five-Year Plan” project HIV testing reagents, the SARS research
of the Ministry of Science and Technology, and the national “Precision Medical
Research” project. He has led the development and application of
multi-disciplinary and multi-platform products in areas such as reproductive
health, infectious diseases and tumor disease detection, and published and
obtained nearly 100 papers, registration certificates and patents. He was
invited to participate in the "Innovative and Sustainable
Development" high-level forum held at the United Nations Headquarters in
New York, the sixth China-Central and Eastern European country leaders
"16+1" signing ceremony as a special guest, and gave speeches as a
representative of BGI as the leader in the global genetics industry. Since
joining BGI in 1998, he has held core leadership positions in research,
intellectual development, industry, and regional fields. He served as the
rotating CEO of the BGI Group in 2017. Mu Feng graduated from the Graduate
School of the Chinese Academy of Sciences with a Ph.D. in Genetics.
